DuPont
DD NYSE· Industrial Conglomerates
Last close · Oct 26, 2026
$136.25
KIRA · Stoqly’s AI analyst, in plain words
- DuPont had $6.8B of revenue in fiscal 2025, up 1.9% on the year before. Over five years, revenue changed −19.6% a year on average.
- DuPont lost $779M in fiscal 2025.
- Free cash flow was $227M in fiscal 2025, 3.3% of revenue.
- DuPont returned $597M to shareholders in fiscal 2025, 263% of free cash flow. The diluted share count rose 0.0%.
- DuPont owes $2.5B more than it holds in cash, about 2.1 years of operating profit.
Market cap
$18.6B
P/E
—
Revenue
$6.8B
Net income
−$779M
Free cash flow
$227M
Operating margin
—
DuPont in 30 seconds · fiscal 2025
Are sales growing?
+1.9%
Only a little. Sales grew 1.9% last year.
Does it make a profit?
−11.4%
No. It lost money last year.
Does profit turn into cash?
3.3%
Partly. 3.3% of sales ends up as free cash.
Is debt under control?
2.1x
Keep an eye on it. Repaying its debt would take 2.1 years of operating profit.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
What DuPont does
DuPont makes engineered materials and parts for other businesses. Its products include medical packaging and components for medical devices and drug makers, water filters and membranes that clean water for industry and cities, building materials such as TYVEK house wrap, STYROFOAM insulation and CORIAN countertops, and industrial parts, adhesives, lubricants and printing plates for aircraft, car and packaging makers. It has subsidiaries in about 50 countries and factories in about 20. It reports two segments. Healthcare & Water Technologies had net sales of $3,233 million in 2025, and Diversified Industrials, which covers the building and industrial products, had $3,616 million. Sales outside the US, including exports, made up about 53 percent of the total. DuPont says it competes with large multinational companies and established regional ones, on technology, price and service. The company has been shrinking to this core.
Biggest risks, in its own words
- Large tax bills if past spin-offs and sales, including the Qnity spin-off, fail to qualify for their intended tax treatment.
- Lawsuits and cleanup costs tied to PFAS chemicals, shared with Corteva and Chemours under a cost-sharing agreement.
- The planned sale of the Aramids business may be delayed or may not happen as planned.
- Its reliance on energy, raw materials and outside suppliers spread across many countries, which can be disrupted.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 17, 2026
- Legal name
- DUPONT DE NEMOURS, INC.
- CIK
- 0001666700
DuPont · DD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $12.6B | $13.0B | $6.6B | $6.7B | $6.8B |
| Revenue growth | −38.4% | 3.6% | −49.2% | 1.6% | 1.9% |
| Gross margin | 36.6% | 35.5% | 32.8% | 33.0% | 34.5% |
| Net income | $6.5B | $5.9B | $423M | $703M | −$779M |
| Net margin | 51.5% | 45.1% | 6.4% | 10.5% | −11.4% |
| Diluted EPS | $11.89 | $11.75 | $0.94 | $1.68 | −$1.86 |
| Cash | |||||
| Cash from operations | $2.3B | $588M | $845M | $765M | $560M |
| Capital expenditure | $788M | $662M | $302M | $285M | $333M |
| Free cash flow | $1.5B | −$74.0M | $543M | $480M | $227M |
| FCF margin | 11.9% | −0.6% | 8.2% | 7.1% | 3.3% |
| Dividends paid | $630M | $652M | $651M | $635M | $597M |
| Share buybacks | $2.1B | $0.0M | $0.0M | $0.0M | $0.0M |
| Share count change | −26.0% | −8.2% | −9.9% | −6.8% | 0.0% |
| Debt and strength | |||||
| Cash and short-term investments | $2.0B | $5.0B | $2.4B | $1.8B | $715M |
| Debt incl. finance leases | $10.8B | $8.1B | $7.9B | $7.2B | $3.2B |
| Shareholders' equity | $26.4B | $26.6B | $24.3B | $23.4B | $13.9B |
| Net debt / EBITDA | 2.9x | 1.0x | 7.8x | 4.8x | 2.1x |
| Current ratio | 2.9x | 3.0x | 2.4x | 3.8x | 2.4x |
| Interest coverage | 3.8x | 3.9x | 0.3x | 1.3x | 1.6x |
| Returns and quality | |||||
| Return on capital | 3.7% | 4.3% | 0.3% | 0.8% | 1.1% |
| Return on equity | 19.9% | 22.1% | 1.7% | 3.0% | −4.2% |
| Piotroski F-score | 6 | 6 | 4 | 9 | 6 |
| Altman Z'' | 1.5 | 1.8 | 0.7 | 2.7 | −0.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.6M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
DuPont · DD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| DuPont DD | $18.6B | 1.9% | — | 3.3% | 1.1% | — | 6 |
| Carlisle Companies CSL | $14.0B | 0.3% | 20.0% | 19.3% | 21.9% | 19.8x | 6 |
| 3M MMM | $90.3B | 1.5% | 18.6% | 5.6% | 34.2% | 25.8x | 5 |
| Honeywell Technologies HON | $70.0B | 7.9% | 21.7% | 14.5% | 17.1% | — | 4 |
| ZIM Integrated Shipping ZIM | $3.6B | −18.1% | 14.7% | 30.2% | 24.9% | — | 4 |
KIRA
At $136.25 a share, the company is worth $18.6B.
DuPont grew sales faster than 3 of its 4 similar companies.
Source: SEC EDGAR XBRL filings (CIK 0001666700). Data updated October 10, 2026. For information only — not investment advice. Check the original filings before relying on any figure.